CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Organogenesis Holdings Inc. - ORGO CFD

3.21
0%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 3.21
Open 3.17
1-Year Change -23.24%
Day's Range 3.16 - 3.22
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 25, 2024 3.19 0.21 7.05% 2.98 3.25 2.98
Jul 24, 2024 3.08 0.01 0.33% 3.07 3.23 3.07
Jul 23, 2024 3.15 0.23 7.88% 2.92 3.16 2.92
Jul 22, 2024 2.99 0.14 4.91% 2.85 3.02 2.84
Jul 19, 2024 2.88 0.06 2.13% 2.82 2.94 2.81
Jul 18, 2024 2.92 -0.06 -2.01% 2.98 3.01 2.89
Jul 17, 2024 3.01 0.02 0.67% 2.99 3.09 2.98
Jul 16, 2024 3.07 0.24 8.48% 2.83 3.07 2.83
Jul 15, 2024 2.87 -0.02 -0.69% 2.89 2.91 2.81
Jul 12, 2024 2.88 -0.04 -1.37% 2.92 2.97 2.86
Jul 11, 2024 2.93 0.09 3.17% 2.84 3.02 2.84
Jul 10, 2024 2.84 0.06 2.16% 2.78 2.84 2.73
Jul 9, 2024 2.76 0.03 1.10% 2.73 2.77 2.68
Jul 8, 2024 2.78 0.00 0.00% 2.78 2.93 2.75
Jul 5, 2024 2.76 0.07 2.60% 2.69 2.77 2.67
Jul 3, 2024 2.76 0.13 4.94% 2.63 2.78 2.62
Jul 2, 2024 2.64 0.01 0.38% 2.63 2.70 2.62
Jul 1, 2024 2.68 -0.14 -4.96% 2.82 2.82 2.68
Jun 28, 2024 2.77 0.13 4.92% 2.64 2.81 2.63
Jun 27, 2024 2.61 0.14 5.67% 2.47 2.65 2.47

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Organogenesis Holdings Inc. Company profile

About Organogenesis Holdings Inc

Organogenesis Holdings Inc. is a regenerative medicine company, which is focused on the development, manufacture, and commercialization of solutions for the wound care and surgical and sports medicine markets. Its solutions address comorbidities such as diabetes, obesity, cardiovascular and peripheral vascular disease, and smoking. The wound care products include Apligraf for the treatment of venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs); Dermagraft for the treatment of diabetic foot ulcer (DFU); PuraPly AM and PuraPly XT as antimicrobial barriers for variety of wound types; and the Affinity and NuShield wound coverings to address a variety of wound sizes and types. Its surgical and sports medicine product includes ReNu for in-office knee osteoarthritis treatment; NuCel for bony fusion in the lumbar spine; NuShield and Affinity barrier products for surgical application in targeted soft tissue repairs; and PuraPly AM for management of open wounds in the surgical setting.

Financial summary

BRIEF: For the nine months ended 30 September 2021,Organogenesis Holdings Inc revenues increased 47% to$339.5M. Net income totaled $43.2M vs. loss of $545K.Revenues reflect an increase in demand for the Company'sproducts and services due to favorable market conditions.Basic Earnings per Share excluding Extraordinary Itemsincreased from -$0.01 to $0.34.

Industry: Biotechnology & Medical Research (NEC)

85 Dan Rd
CANTON
MASSACHUSETTS 02021-2810
US

People also watch

XRP/USD

0.61 Price
+1.640% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

67,928.50 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,281.07 Price
+4.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading